The Wellbeing of Infants Exposed to Buprenorphine via Breast Milk at 4 Weeks of Age

Abstract

Background:

Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital.

Objective:

The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatally.

Methods:

Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation.

Results:

Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours.

Conclusion:

No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Further research using larger samples to assess possible developmental effects over longer periods of time is required.

Keywords

breastfeeding drug-exposed infants infant health substance abuse

Get full access to this article

View all access options for this article.

References

Ohtani

Kotaki

Sawada

Iga

. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther. 1995;272(2):505-510.

Ohtani

Kotaki

Nishitateno

Sawada

Iga

. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J Pharmacol Exp Ther. 1997;281(1):428-433.

Australian Government Department of Health and Ageing. National Pharmacotherapy Policy for People Dependent on Opioids. Canberra: DoHA for the National Drug Strategy; 2007.

Hale

. Medications and Mothers’ Milk: A Manual of Lactational Pharmacology. 15th ed. Amarillo, TX: Hale Publishing; 2012.

Fischer

Ortner

Rohrmeister

. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101(2):275-281.

Lejeune

Simmat-Durand

Gourarier

Aubisson

. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend. 2006;82(3):250-257.

Jones

Johnson

Jasinski

. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79(1):1-10.

Loustauneau

Auriacombe

Daulouede

Tignol

. Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature [in French]. Ann Med Interne (Paris). 2002;153(suppl 7):2S31-2S36.

Bartu

Ilett

Hackett

Doherty

Hamilton

. Buprenorphine exposure in infants of opioid-dependent mothers at birth. Aust N Z J Obstet Gynaecol. 2012;52(4):342-347.

10.

Ilett

Hackett

Gower

Doherty

Hamilton

Bartu

. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Breastfeed Med. 2012;7:269-274.

11.

Marquet

Chevrel

Lavignasse

Merle

Lachatre

. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997;62(5):569-571.

12.

Grimm

Pauly

Poschl

Linderkamp

Skopp

. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Ther Drug Monit. 2005;27(4):526-530.

13.

Lindemalm

Nydert

Svensson

Stahle

Sarman

. Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact. 2009;25(2):199-205.

14.

Johnson

RE.

Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001;63(1):7-7.

15.

Jones

Heil

Baewert

. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012;107(suppl 1):5-27.

16.

Finnegan

Kaltenbach

. Neonatal abstinence syndrome. In: Hoekelman

Adam

Nelson

Weitzman

Wilson

, eds. Primary Pediatric Care. 2nd ed. St Louis, MO: CV Mosby; 1992:1367-1378.

17.

Australian Bureau of Statistics. Australia’s Babies. Canberra: Commonwealth of Australia; 2007. Catalogue no. 4102.0.

18.

D’Apolito

. Neonatal opiate withdrawal: pharmacologic management. Newborn Infant Nurs Rev. 2009;9(1):62-69.

19.

Osborn

Jeffery

Cole

. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;(10):CD002053.

20.

Australian Breastfeeding Association. Breastfeeding Rates in Australia. Malvern: Australian Breastfeeding Association; 2004.

21.

Wachman

Byun

Philipp

. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med. 2010;5(4):159-164.

22.

World Health Organization. Health topics: breastfeeding. Geneva, Switzerland: World Health Organization. http://www.who.int/topics/breastfeeding/en/. Accessed July 2, 2012.

23.

Bartu

Sharp

Ludlow

Doherty

. Postnatal home visiting for illicit drug-using mothers and their infants: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2006;46(5):419-426.

24.

Schindler

Eder

Ortner

Rohrmeister

Langer

Fischer

. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction. 2003;98(1):103-110.

25.

Johnson

Jones

Fischer

. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(2):S87-S101.

26.

Johnson

Jones

Jasinski

. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001;63(1):97-103.

27.

Kayemba-kays

Laclyde

. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Addiction. 2003;98(11):1599-1604.

28.

O’Connor

Alto

Musgrave

. Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes. J Am Board Fam Med. 2011;24(2):194-201.

29.

Kuczmarski

Ogden

Guo

. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat. 2002;11(246):1-190.

30.

Hyams

Treem

Etienne

. Effect of infant formula on stool characteristics of young infants. Pediatrics. 1995;95(1):50-54.

31.

Biancuzzo

. Breastfeeding the Newborn: Clinical Strategies for Nurses. 2nd ed. St Louis, MO: Mosby; 2003.

32.

Griffin

Beattie

. Normal bowel habit during the first 6 weeks in healthy, term infants. Ambulatory Child Health. 2001;7(1):23-26.

33.

Inan

. Childhood constipation and diet. Ped Health. 2009;3(4):353-358.

34.

Coughlin

. Assessment and management of pediatric constipation in primary care. Pediatr Nurs. 2003;29(4):296-301.

35.

Armstrong

Quinn

Dadds

. The sleep patterns of normal children. Med J Aust. 1994;161(3):202-206.

36.

St James-Roberts

Sleep

Morris

Owen

Gillham

. Use of a behavioural programme in the first 3 months to prevent infant crying and sleeping problems. J Paediatr Child Health. 2001;37(3):289-297.

37.

Gross

Resnik

Nanda

. Early postpartum: a critical period in setting the path for breastfeeding success. Breastfeed Med. 2011;6(6):407-412.

38.

Bai

Middlestadt

Peng

Fly

. Predictors of continuation of exclusive breastfeeding for the first six months of life. J Hum Lact. 2010;26(1):26-34.

39.

Australian Institute of Health and Welfare. National Opioid Pharmacotherapy Statistics Annual Data Collection 2010 Report. Canberra: AIHW; 2011. Catalogue no. HSE 109.

40.

Vohr

Poindexter

Dusick

. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics. 2006;118(1):e115-e123.

41.

Garofolo

Goldman

. Expression of functional immunomodulatory and anti-inflammatory factors in human milk. Clin Perinatol. 1999;26(2):361-377.

42.

Arora

McJunkin

Wehrer

Kuhn

. Major factors influencing breastfeeding rates: mother’s perception of father’s attitude and milk supply. Pediatrics. 2000;106(5):E67.

43.

Callen

Pinelli

. Review of the literature examining the benefits and challenges, incidence and duration, and barriers to breastfeeding in preterm infants. Adv Neonatal Care. 2005;5(2):72-88.